Key takeaways
- The estrobolome is the set of gut bacteria carrying genes for beta-glucuronidase, the enzyme that cleaves the glucuronide the liver attached to oestrogen for disposal.
- Deconjugated oestrogen is free, active and reabsorbed through enterohepatic recirculation rather than excreted, so high enzymatic activity raises circulating oestrogen and low activity lowers it.
- Circulating oestrogen is therefore production minus excretion, and the gut sets the excretion term.
- There is currently no validated clinical test, no established reference range, and no supplement with evidence for modifying oestrogen recycling.
- Fibre from varied sources, plant diversity, fermented foods, less alcohol and fewer unnecessary antibiotics are the interventions, and all of them are worth doing anyway.
Most explanations of oestrogen stop at production. The ovaries make it, the liver deactivates it, the body excretes it. That account is incomplete in a way that matters, because a substantial share of the oestrogen the liver has already packaged for disposal never leaves the body. It gets unpackaged in the gut by bacterial enzymes and reabsorbed into circulation. How much depends on which bacteria are present. That population has a name — the estrobolome — and it is a genuine, measurable influence on hormone status that sits entirely outside the ovaries.
What the estrobolome is
The estrobolome is the collection of gut bacteria carrying genes for enzymes that act on oestrogens (Baker et al., Maturitas 2017). It is defined functionally rather than taxonomically — it is not one species or one genus, but whichever organisms in a given person's gut happen to carry the relevant genes.
That definition is important because it explains why two people with quite different microbial compositions can have similar oestrogen recycling, and why a single "good bacteria" framing does not apply. What varies between people is enzymatic capacity, and that capacity varies a great deal.
The loop, step by step
Oestrogen disposal is a five-step process, and the gut sits at step four.
- The liver conjugates oestrogen with glucuronic acid. This deactivates the hormone and makes it water-soluble, which is what allows it to be excreted.
- The conjugated oestrogen is secreted into bile.
- Bile empties into the small intestine.
- Gut bacteria expressing beta-glucuronidase cleave the glucuronide off. The oestrogen is now unconjugated — free, active and lipid-soluble again.
- Free oestrogen is reabsorbed across the intestinal wall and returns to circulation via the portal vein. This is enterohepatic recirculation.
Step four is the control point, and it is entirely bacterial. High beta-glucuronidase activity means more of what the liver deactivated gets reactivated and returned; low activity means more of it continues into the stool and leaves (Ervin et al., J Biol Chem 2019).
The consequence is worth stating plainly: circulating oestrogen is not simply a function of how much is produced. It is production minus excretion, and the gut sets the excretion term.
How strong is the evidence
This is the section most articles on the topic skip, and it is the one that determines how much weight to put on the rest.
The enzymology is solid. Bacterial beta-glucuronidases have been characterised, their action on oestrogen conjugates demonstrated directly, and the enterohepatic loop is basic physiology rather than a hypothesis. The population-level associations are real too: faecal microbial diversity and richness correlate with urinary oestrogen and oestrogen metabolite profiles in postmenopausal women (Fuhrman et al.).
What is much weaker is the step from there to individual clinical decisions. There is no validated clinical test that tells you your beta-glucuronidase activity in a way that changes management. There is no established threshold, no reference range, and no intervention with trial evidence showing that modifying the estrobolome improves a hormonal outcome someone cares about. The dietary evidence that does exist is largely observational and decades old — vegetarian women excrete more oestrogen in faeces and have lower plasma levels than omnivorous women, which fits the mechanism but does not isolate it (Goldin et al., N Engl J Med 1982).
So the honest summary is: real mechanism, plausible clinical relevance, no diagnostic test worth paying for, and interventions that are worth doing for other reasons anyway.
What this does and does not explain
It offers a coherent reason why hormone status can shift without anything changing at the ovary. A course of broad-spectrum antibiotics alters the enzymatic capacity of the gut for weeks; a sustained change in fibre intake alters it over months. Neither event touches production.
It also gives some structure to the vaguer end of the "oestrogen dominance" conversation — a term used loosely and often without measurement. Some of what gets described that way plausibly has a recycling component rather than a production one. That is a mechanism worth knowing about, not a diagnosis; oestrogen dominance, real or myth covers where the term holds up and where it does not.
What it does not explain is most of what people try to attach to it. It is not the reason for menopausal symptoms, which are driven by ovarian output falling. It is not a substitute for measuring hormones — the complete hormone panel covers what actually gets measured. And it is not a reason to delay evaluating a symptom that has a straightforward explanation available.
What disrupts it
The inputs that shift gut community composition are the same ones that shift it for every other reason: antibiotics, particularly broad-spectrum courses; a low-fibre diet, which is the default in most Western eating patterns; high intake of ultra-processed food; chronic alcohol; sustained psychological stress, which affects gut motility, secretion and barrier function; inadequate sleep; and some medications including proton pump inhibitors, which change gastric acidity and therefore what survives into the small intestine.
None of these is exotic. The estrobolome is not a separate system with separate rules — it is the gut microbiome, viewed through one particular functional lens.
What actually helps
- Fibre, from varied sources, at 25-35 g daily. This is the highest-leverage item and the one most people fall short on by a wide margin. Variety matters as much as total, because different fibres feed different organisms. The fibre gap covers how large the shortfall typically is.
- Diverse plant intake. Diversity of input is the most consistent correlate of diversity of gut community across the literature.
- Fermented foods — yoghurt, kefir, sauerkraut, kimchi. Modest evidence, low cost, no downside.
- Fewer unnecessary antibiotics. Not an argument against necessary ones; an argument against the marginal ones.
- Less alcohol, which affects both the gut and hepatic oestrogen handling directly.
- Sleep and stress, which act on the gut through motility and barrier function rather than through anything mystical.
- Probiotics — the weakest item on this list. Specific strains may help specific things, the data is still emerging, and no commercially available product has evidence for modifying oestrogen recycling in particular.
A high-fibre, plant-diverse eating pattern is not a niche protocol; building it into ordinary meals is more effective than supplementing around a diet that lacks it, and a structured recipe system makes the fibre and protein targets land in the same meals rather than competing.
The clinical pearl: the estrobolome is a real link between gut and hormonal health, and it is also the most over-sold concept in that space. There is currently no test worth ordering and no supplement worth buying for it specifically. What there is: a mechanistic reason why fibre, alcohol and antibiotic exposure show up in hormone conversations, and a reason not to treat gut health as unrelated when a hormonal picture is not adding up.
When it is worth considering
The situations where this belongs in the discussion are narrow but real. Persistent symptoms despite hormone levels that look appropriate. A hormonal picture that shifted noticeably after a significant antibiotic course or a major dietary change. Long-standing gastrointestinal symptoms alongside hormonal ones, where treating them as two separate problems has not worked. In each case the estrobolome is a reason to widen the evaluation, not a conclusion to arrive at.
Bottom line
Gut bacteria producing beta-glucuronidase deconjugate oestrogen that the liver had already prepared for excretion, allowing it to be reabsorbed instead. That makes the gut a genuine determinant of circulating oestrogen alongside production. The mechanism is well established; the clinical application is not. There is no validated test, no evidence-backed supplement, and no threshold to treat toward. What the concept earns is a place in the evaluation when a hormonal picture does not fit, and a good reason to take fibre, alcohol and antibiotic exposure seriously — all of which are worth doing regardless of what any bacterial enzyme is doing.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
